The 15-minute chart for Electromed has exhibited a KDJ Death Cross and a Bearish Marubozu at 10/17/2025 10:45, indicating a shift in the stock price's momentum towards the downside and a potential for further decline. The sellers are currently in control of the market, and the bearish momentum is likely to persist.
Electromed Inc. (ELMD), a leading provider of advanced airway clearance solutions, has been exhibiting bearish market indicators on its 15-minute chart. As of October 17, 2025, at 10:45 AM, the stock experienced a KDJ Death Cross and a Bearish Marubozu, signaling a potential shift in momentum towards the downside. These indicators suggest that sellers are currently in control of the market, and the bearish momentum is likely to persist, according to a
.
Despite the bearish indicators, Electromed has reported strong financial performance in its recent quarters. For the fourth quarter of fiscal 2025, the company achieved record quarterly revenue of $17.4 million, up 17.3% year-over-year, and record annual revenue of $64.0 million, up 17.0%. The company's net income for the quarter reached $2.2 million ($0.25 per share), while the full-year net income was $7.5 million ($0.85 per share).
Electromed has also demonstrated a commitment to enhancing shareholder value through share repurchases. The company's Board of Directors approved a $10.0 million share repurchase authorization on September 9, 2025, following the completion of its previous buyback program in Q4 2025. This decision reflects strong operational performance and robust cash reserves.
The company's participation in various conferences and events underscores its engagement with the investment community. Electromed will participate in the LD Micro Main Event XIX in San Diego from October 19-21, 2025, where CEO Jim Cunniff will present on October 20, 2025, at 10:00 AM PT.
Electromed's inclusion in the Russell 2000® and Russell 3000® indexes further validates its position in the market. The company was added to these indices effective June 27, 2025, as part of FTSE Russell's 2025 annual reconstitution.
Investors should closely monitor Electromed's financial performance and market indicators to make informed decisions. The bearish momentum on the 15-minute chart suggests a potential decline in the stock price, but the company's strong financial results and share repurchases indicate a commitment to long-term growth and shareholder value.
References
Comments
No comments yet